AMWL
American Well Corporation
AMWL's outlook is improving, though it still trails on the overall score.
LLY
Eli Lilly and Company
LLY has the edge over AMWL overall, supported by stronger fundamentals and lower modeled downside.
AMWL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Unavailable |
AMWL's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMWL PE Valuation
AMWL has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
AMWL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMWL's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over AMWL on the outlook, with more favorable revenue expectations.
AMWL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.45 | +$3.63 |
| Q2 2026 | -$4.78 | +$3.17 |
| Q1 2026 | -$5.43 | +$4.64 |
| Q4 2025 | -$5.96 | +$7.92 |
| Q3 2025 | -$7.08 | +$7.15 |
| Q2 2025 | -$7.95 | +$13.01 |
| Q1 2025 | -$10.07 | +$14.13 |
| Q4 2024 | -$13.88 | +$33.72 |
AMWL is still losing money, but far less than before: $3.45 per share over the past year, against $81.23 at its worst in late 2020.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over AMWL on earnings quality, reporting a profit while its opponent remains loss making.
AMWL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49M | -13% |
| Q2 2026 | $52M | -27% |
| Q1 2026 | $54.9M | -18% |
| Q4 2025 | $55.3M | -22% |
| Q3 2025 | $56.3M | -7.8% |
| Q2 2025 | $70.9M | +13% |
| Q1 2025 | $66.8M | +12% |
| Q4 2024 | $71M | +0.5% |
AMWL's revenue has slid since its 2022 peak: $49M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -24% | +28 points |
| Q2 2026 | -18% | +10 points |
| Q1 2026 | -32% | +14 points |
| Q4 2025 | -45% | +15 points |
| Q3 2025 | -52% | +26 points |
| Q2 2025 | -29% | +55 points |
| Q1 2025 | -46% | +81 points |
| Q4 2024 | -60% | +20 points |
AMWL's operating margin was −24% last quarter, up 28 points from the same quarter a year ago, near the top of its range since 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over AMWL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over AMWL on profitability, with a higher operating margin.
AMWL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.7M | +$7.1M |
| Q2 2026 | $10.7M | +$15.4M |
| Q1 2026 | -$988K | +$24.1M |
| Q4 2025 | -$17.4M | -$3.9M |
| Q3 2025 | -$18.8M | +$13.6M |
| Q2 2025 | -$4.7M | +$17.1M |
| Q1 2025 | -$25.1M | +$34.7M |
| Q4 2024 | -$13.4M | +$28.2M |
AMWL has burned cash in almost every quarter: −$19M over the past year, against −$62M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over AMWL on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMWL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +299K shares |
| 1 year | +5.2% | +845K shares |
| 3 years | +19% | +2.8M shares |
| 5 years | +33% | +4.2M shares |
| Available history | +772% | +15.1M shares |
AMWL has 17M diluted shares, up 5.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1,000 |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $1,000 |
| Q3 2025 | $1,000 |
| Q2 2025 | $1,000 |
| Q1 2025 | $1,000 |
| Q4 2024 | $2,000 |
AMWL has spent almost nothing on buybacks in the past year.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over AMWL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
AMWL Net Leverage
AMWL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
AMWL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.2 | Neutral |
| Stochastic | 37.6 | Neutral |
AMWL's weekly RSI is 54 (neutral) and its Stochastic is 38 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
AMWL PE vs Healthcare Sector
AMWL has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
AMWL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.6 | 4.1% below |
| 20 week MA | $12.2 | 1.4% below |
| 50 week MA | $8.53 | 41% above |
| 100 week MA | $7.98 | 51% above |
| 200 week MA | $17.1 | 30% below |
AMWL's trend is mixed: it's above two of its five weekly moving averages, and 30% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over AMWL on trend strength, trading above more of its moving averages.
AMWL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $460.4 | $595.0 | +29% |
| 2021 | $595.0 | $128.6 | -78% |
| 2022 | $128.6 | $61.6 | -52% |
| 2023 | $61.6 | $29.8 | -52% |
| 2024 | $29.8 | $7.80 | -74% |
| 2025 | $7.80 | $4.55 | -42% |
| 2026 YTD | $4.55 | $12.0 | +164% |
AMWL has the edge over LLY on returns for 2026, with the stronger performance.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.